| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 05/27/1999 | WO1999025721A1 Detection and treatment of retinal degenerative disease |
| 05/27/1999 | WO1999025387A1 Recombinant vaccines comprising immunogenic attenuated bacteria having rpos positive phenotype |
| 05/27/1999 | WO1999025386A1 delta-O6-METHYLGUANINE-DNA METHYLTRANSFERASE GENE TRANSFER FOR O6-BENZYLGUANINE AND (N,N'-BIS(2-CHLOROETHYL)-N-NITROSOUREA) RESISTANCE |
| 05/27/1999 | WO1999025385A1 A method of increasing nucleic acid synthesis with ultrasound |
| 05/27/1999 | WO1999025379A1 Modified antibodies with enhanced ability to elicit an anti-idiotype response |
| 05/27/1999 | WO1999025378A1 Immunoglobulin molecules having a synthetic variable region and modified specificity |
| 05/27/1999 | WO1999025373A1 Modulation of drug resistance via ubiquitin carboxy-terminal hydrolase |
| 05/27/1999 | WO1999025324A1 Administering active substances by using the capsid produced out of the polyoma virus vp1 protein |
| 05/27/1999 | WO1999025320A1 Targeted liposome gene delivery |
| 05/27/1999 | WO1999025195A1 Purging of stem cell products |
| 05/27/1999 | WO1999014346A3 SENSE mRNA THERAPY |
| 05/27/1999 | WO1999013092A9 Enhancement of mucosal antibody responses by interleukin-6 |
| 05/27/1999 | WO1999012964A3 Kay - a novel immune system protein |
| 05/27/1999 | WO1999011780A3 Conductine protein and a related agent for diagnosing and treating tumor illnesses |
| 05/27/1999 | WO1999011758A3 Cultures of human cns neural stem cells |
| 05/27/1999 | WO1999010480A3 New tissue-specific calpaines, their production and their use |
| 05/27/1999 | WO1998055495A3 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof |
| 05/27/1999 | WO1998049292A3 Polypeptides associated with activator receptors and their biological applications |
| 05/27/1999 | DE19750702A1 Antisense oligonucleotides that bind to sequences encoding human tenascin for treating depigmentation, cancer, inflammation and cardiovascular disease |
| 05/27/1999 | DE19750354A1 Covering an inductor molecule with a viral capsid, for more efficient transfection of cells |
| 05/27/1999 | CA2739604A1 Targeted liposome gene delivery |
| 05/27/1999 | CA2310563A1 Vector for tissue-specific replication and gene expression |
| 05/27/1999 | CA2310328A1 Purging of stem cell products |
| 05/27/1999 | CA2310269A1 Immunoglobulin molecules having a synthetic variable region and modified specificity |
| 05/27/1999 | CA2310016A1 Genetically-modified myogenic progenitors and their use in cell and gene therapy |
| 05/27/1999 | CA2309990A1 Modified antibodies with enhanced ability to elicit an anti-idiotype response |
| 05/27/1999 | CA2309904A1 Transfection and transfer of male germ cells for generation of transgenic species |
| 05/27/1999 | CA2309758A1 Reagents and methods useful for detecting diseases of the breast |
| 05/27/1999 | CA2309390A1 Cdk2 protein and cdk2 protein complexes |
| 05/27/1999 | CA2309339A1 Transcriptionally regulated g protein-coupled receptor |
| 05/27/1999 | CA2306492A1 Human checkpoint kinase, hcds1, compositions and methods |
| 05/26/1999 | EP0917591A1 23s rna nucleotide fragment of the clhamydia genus bacteria, uses as probe, primer, and in a reagent and a detection and a detection method |
| 05/26/1999 | EP0917586A1 Vector for activating the immune system against cells associated to papilloma viruses or sequences thereof |
| 05/26/1999 | EP0917585A2 Vectors for delivering viral and oncogenic inhibitors |
| 05/26/1999 | EP0917581A1 Fusion polypeptides com0prising an ige-binding domain and a hsa component, and their diagnostic and therapeutic uses |
| 05/26/1999 | EP0917577A2 Herpes simplex virus icp4 is an inhibitor of apoptosis |
| 05/26/1999 | EP0917575A1 Use of a lestr/fusin/cxcr4 receptor ligand chemokine (sdf-1) for treating or preventing hiv-type viral infection |
| 05/26/1999 | EP0917572A2 Secreted proteins and polynucleotides encoding them |
| 05/26/1999 | EP0917428A1 Hybrid matrix implants and explants |
| 05/25/1999 | US5906976 Method and composition for treating neuronal degeneration |
| 05/25/1999 | US5906938 Method of reconstituting hematopoietic cells using monoclonal antibodies to the stem cell factor receptor |
| 05/25/1999 | US5906935 Cells transformed or transfected with HCMV US2-US5, US10-US11 genes |
| 05/25/1999 | US5906922 Delivery of nucleic acids |
| 05/25/1999 | US5906821 Viral nucleotide sequences |
| 05/25/1999 | US5906817 Biocompatible implant for the expression and in vivo secretion of a therapeutic substance |
| 05/21/1999 | CA2251257A1 Oncogene- or virus-controlled expression systems |
| 05/20/1999 | WO1999024836A1 125 human secreted proteins |
| 05/20/1999 | WO1999024595A1 The translation enhancer element of the human amyloid precursor protein gene |
| 05/20/1999 | WO1999024584A1 Methods for the detection and treatment of disease using a glycosyltransferase |
| 05/20/1999 | WO1999024583A1 Dna demethylase, therapeutic and diagnostic uses thereof |
| 05/20/1999 | WO1999024578A2 Neisserial antigens |
| 05/20/1999 | WO1999024571A2 Differentially expressed genes in cardiac hypertrophy and their uses in treatment and diagnosis |
| 05/20/1999 | WO1999024566A1 Tumor-specific antigens, methods for their production and their use for immunization and diagnosis |
| 05/20/1999 | WO1999024565A1 Methods and compositions for immunomodulation |
| 05/20/1999 | WO1999024559A2 Nuclear targeting by means of streptococcal protein h |
| 05/20/1999 | WO1999024469A1 Secreted proteins and polynucleotides encoding them |
| 05/20/1999 | WO1999024078A1 Prevention of immunoreactivity by depleting or inhibiting antigen presenting cells |
| 05/20/1999 | WO1999024056A1 Regulation of ocular angiogenesis |
| 05/20/1999 | WO1999023879A1 Method for the augmentation of gene expression |
| 05/20/1999 | WO1999023867A2 Bmog, a protein member of the myelin-oligodendrocyte glycoprotein family and its use |
| 05/20/1999 | WO1999015649A3 Composition and method for enhancing paracellular transport across cell layers |
| 05/20/1999 | WO1999015553A3 Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use |
| 05/20/1999 | WO1999010505A3 Production of proteins in eggs |
| 05/20/1999 | WO1999009167A8 Porcine mhc class i genes and uses thereof |
| 05/20/1999 | WO1999007736A3 Lipoprotein-regulating medicaments |
| 05/20/1999 | WO1999006557A3 Mammalian cell membrane proteins; related reagents |
| 05/20/1999 | WO1999006549B1 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN TESTIS AND OTHER TISSUES |
| 05/20/1999 | WO1998048785A9 Allelic polygene diagnosis of reward deficiency syndrome and treatment |
| 05/20/1999 | WO1998031796A8 Novel ifn receptor 1 binding proteins, dna encoding them, and methods of modulating cellular response to interferons |
| 05/20/1999 | DE19750220A1 Producing polyoma virus-like particles in yeast for gene therapy, vaccine development and diagnosis |
| 05/20/1999 | CA2671261A1 Neisserial antigens |
| 05/20/1999 | CA2310575A1 Method for the augmentation of gene expression |
| 05/20/1999 | CA2309640A1 Nuclear targeting by means of bacterial proteins |
| 05/20/1999 | CA2309557A1 Tumor-specific antigens, methods for their production and their use for immunization and diagnosis |
| 05/20/1999 | CA2309535A1 The translation enhancer element of the human amyloid precursor protein gene |
| 05/20/1999 | CA2309360A1 Differentially expressed genes in cardiac hypertrophy and their uses in treatment and diagnosis |
| 05/20/1999 | CA2309007A1 Secreted proteins and polynucleotides encoding them |
| 05/20/1999 | CA2308768A1 125 human secreted proteins |
| 05/20/1999 | CA2308606A1 Neisserial antigens |
| 05/20/1999 | CA2308440A1 Bmog, a protein member of the myelin-oligodendrocyte glycoprotein family and its use |
| 05/19/1999 | EP0916737A2 Polynucleotide compounds for hybridizing to target polynucleotides |
| 05/19/1999 | EP0916729A2 Novel reductase |
| 05/19/1999 | EP0916727A2 Novel LysS |
| 05/19/1999 | EP0916074A1 Magnetic rotation sensor |
| 05/19/1999 | EP0915978A2 Dna immunization against chlamydia infection |
| 05/19/1999 | EP0915975A2 Methods for administration of recombinant gene delivery vehicles for treatment of hemophilia |
| 05/19/1999 | EP0915974A1 Modified tie-2-receptor ligands |
| 05/19/1999 | EP0915973A1 Gene involved in cadasil, method of diagnosis and therapeutic application |
| 05/19/1999 | EP0915904A1 Mammalian sex comb on midleg (mammalian scm) acts as a tumor suppressor |
| 05/19/1999 | EP0915709A1 The use of proteinase inhibitors for prevention or reduction of bone resorption |
| 05/19/1999 | EP0915706A1 Screening methods for compounds useful in the regulation of body weight |
| 05/19/1999 | EP0804456A4 Peptide nucleic acid conjugates |
| 05/19/1999 | EP0662837B1 Use of il-10 to prevent insulin-dependent diabetes mellitus |
| 05/19/1999 | EP0434747B1 RECOMBINANT VACCINES BASED ON THE gB-PROTEIN OF MAREK'S DISEASE VIRUS |
| 05/19/1999 | CN1217027A Parapoxviruses contg. foreign DNA, their prodn. and their use in vacciens |
| 05/19/1999 | CN1217025A Processed polypeptides with IL-16 activity, process for preparing same and their use |
| 05/19/1999 | CN1217024A Chemokine alpha 2 |
| 05/19/1999 | CN1216994A Apoptosis inducing molecule II |
| 05/18/1999 | US5904920 Regulation of systemic immune responses utilizing cytokines and antigens |
| 05/14/1999 | WO1999023253A1 Stromal cell derived factor-1 (sdf-1) and method of use for diagnostic and prognostic indicator of aids pathogenesis |